• Home
  • News
  • Coins2Day 500
  • Tech
  • Finance
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Health

FDA Issues a Recall of the Popular High Blood Pressure Drug Hydrochlorothiazide

By
Brittany Shoot
Brittany Shoot
Down Arrow Button Icon
By
Brittany Shoot
Brittany Shoot
Down Arrow Button Icon
August 29, 2018, 7:15 PM ET

Another day, another drug recall from the Food and Drug Administration (FDA) due to a potentially deadly mixup. Accord Healthcare, Inc. Is voluntarily recalling a single lot of mislabeled 100-count bottles of hydrochlorothiazide 12.5 mg tablets. Hydrochlorothiazide is used to treat hypertension, also known as high blood pressure. If used incorrectly, the effects could be life-threatening.

Bottles of 100 tablets of hydrochlorothiazide were incorrectly labeled and instead contained 100 25 mg tablets of spironolactone, according to a patient complaint made through a pharmacy. Spironolactone can also be used to treat high blood pressure, but the FDA warns that use of spironolactone tablets instead of hydrochlorothiazide tablets poses the risk of contracting hyperkalemia, an increase in potassium levels that be life-threatening to certain individuals. It is also possible that taking spironolactone instead of hydrochlorothiazide can have limited consequences, but as with any product recall, there is no reason to roll the dice.

A single lot of the drug, PW05264, is being recalled. Accord is also reaching out to pharmacists and retailers, as well as wholesalers and distributors.

So far, there have been no reports of anyone getting sick. But consumers and pharmacists are encouraged to contact Accord Healthcare by phone at 1-855-869-1081 from Monday to Friday during business hours 8 a.m. To 5 p.m. Eastern time, or by email at [email protected].

About the Author
By Brittany Shoot
See full bioRight Arrow Button Icon
Rankings
  • 100 Best Companies
  • Coins2Day 500
  • Global 500
  • Coins2Day 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Coins2Day Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Coins2Day Brand Studio
  • Coins2Day Analytics
  • Coins2Day Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Coins2Day
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Coins2Day Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Coins2Day Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.